Karina Narbute

3 Jelgavas St
Riga, RIX 1004, Latvia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Extracellular vesicles produced by a large-scale protocol are therapeutically effective in preclinical model of Parkinson's disease.

Extracellular vesicles produced by a large-scale protocol are therapeutically effective in preclinical model of Parkinson's disease.

Journal: Stem cells translational medicine

Published: September 29, 2025

Low-Dose Intranasal Metformin Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer's Disease.

Low-Dose Intranasal Metformin Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer's Disease.

Journal: Molecular neurobiology

Published: February 20, 2025

Development of Organ-on-a-Chip System with Continuous Flow in Simulated Microgravity.

Development of Organ-on-a-Chip System with Continuous Flow in Simulated Microgravity.

Journal: Micromachines

Published: December 29, 2023

iPSC-derived lung and lung cancer organoid model to evaluate cisplatin encapsulated autologous iPSC-derived mesenchymal stromal cell-isolated extracellular vesicles.

iPSC-derived lung and lung cancer organoid model to evaluate cisplatin encapsulated autologous iPSC-derived mesenchymal stromal cell-isolated extracellular vesicles.

Journal: Stem cell research & therapy

Published: December 19, 2023

Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.

Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease.

Journal: European journal of pharmacology

Published: February 23, 2020

Time-Dependent Memory and Gait Improvement by Intranasally-Administered Extracellular Vesicles in Parkinson's Disease Model Rats.

Time-Dependent Memory and Gait Improvement by Intranasally-Administered Extracellular Vesicles in Parkinson's Disease Model Rats.

Journal: Cellular and molecular neurobiology

Published: January 16, 2020

GABA-containing compound gammapyrone protects against brain impairments in Alzheimer's disease model male rats and prevents mitochondrial dysfunction in cell culture.

GABA-containing compound gammapyrone protects against brain impairments in Alzheimer's disease model male rats and prevents mitochondrial dysfunction in cell culture.

Journal: Journal of neuroscience research

Published: October 01, 2018

Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.

Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.

Journal: Stem cells translational medicine

Published: July 30, 2018

Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.

Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.

Journal: Neuropharmacology

Published: May 16, 2018

Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease.

Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease.

Journal: European journal of pharmacology

Published: May 31, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026